Literature DB >> 1845017

[Concentrations of serum lipids in children with Down's syndrome].

A Zamorano1, M Guzmán, M Aspillaga, A Avendaño, M Gatica.   

Abstract

The level of blood lipids in children with Down's syndrome was determined with the purpose of establishing possible differences in total cholesterol, triglyceride and HDL-cholesterol levels with those of healthy children. LDL-cholesterol fraction was calculated. Blood samples were obtained from 66 healthy children (controls) and 72 patients who suffered from clinically diagnosed Down's syndrome. All the children were grouped according to age. The variables of body weight, height, and blood lipids gave a distribution of values that allows one to distinguish the group of children with Down's syndrome from the normal group. The values obtained for triglycerides, total cholesterol, and LDL-cholesterol ranged higher, with a constant deficit of HDL-cholesterol in all age groups. The lipid pattern encountered in the Down's syndrome patient suggests the existence of unknown, possibly genetically determined mechanisms, that provoke a disorder in lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845017

Source DB:  PubMed          Journal:  Arch Biol Med Exp (Santiago)        ISSN: 0004-0533


  5 in total

1.  New onset focal weakness in children with Down syndrome.

Authors:  Gordon Worley; Rolla Shbarou; Amy N Heffner; Karin M Belsito; George T Capone; Priya S Kishnani
Journal:  Am J Med Genet A       Date:  2004-07-01       Impact factor: 2.802

2.  Lipid profiles of children with Down syndrome compared with their siblings.

Authors:  Tahira Adelekan; Sheela Magge; Justine Shults; Virginia Stallings; Nicolas Stettler
Journal:  Pediatrics       Date:  2012-05-14       Impact factor: 7.124

3.  LDL receptor expression on T lymphocytes in old patients with Down syndrome.

Authors:  Massimiliano M Corsi; Alexis E Malavazos; Daniele Passoni; Federico Licastro
Journal:  Immun Ageing       Date:  2005-02-10       Impact factor: 6.400

Review 4.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

5.  Evaluation of biochemical and hematological parameters in adults with Down syndrome.

Authors:  David de Gonzalo-Calvo; Isabel Barroeta; Madalina Nicoleta Nan; José Rives; Diana Garzón; María Carmona-Iragui; Bessy Benejam; Laura Videla; Susana Fernández; Miren Altuna; Sílvia Valldeneu; Rafael Blesa; Alberto Lleó; Francisco Blanco-Vaca; Juan Fortea; Mireia Tondo
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.